Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How has the male infertility market size changed in recent years, and what is the outlook ahead?
The male infertility market size has grown strongly in recent years. It will grow from $3.59 billion in 2024 to $3.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising awareness of male reproductive health, increasing prevalence of lifestyle-related disorders, growing adoption of assisted reproductive technologies (ART), expansion of fertility clinics and diagnostic centers, and advancements in semen analysis technologies.
The male infertility market size is expected to see strong growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing focus on genetic and epigenetic factors, rising demand for personalized infertility treatments, growth in medical tourism for fertility care, technological innovations in sperm retrieval and preservation, and the emerging role of telehealth in fertility consultations. Major trends in the forecast period include increasing use of genetic testing for infertility diagnosis, advancements in sperm retrieval techniques like micro-TESE, growing demand for non-invasive fertility treatments, introduction of personalized male fertility treatment plans, and rising use of stem cell therapy for spermatogenesis restoration.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp
What are the top economic and technological drivers pushing male infertility market growth?
The increasing stress levels are expected to propel the growth of the male infertility market going forward. Stress levels refer to the intensity of emotional, physical, or mental strain experienced in response to challenging situations or pressures. The rising stress levels stem from escalating work demands, where relentless pressure and high expectations cause burnout and disrupt mental health and work-life balance. Elevated stress levels can interfere with hormone balance, decrease sperm quality, and impair sexual function, leading to male infertility. Chronic stress disrupts cortisol and testosterone levels, contributing to a rise in infertility cases. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization of psychologists, 43% of adults in the US felt more anxious in 2024, compared to 37% in 2023 and 32% in 2022, indicating a consistent increase in anxiety levels. Therefore, the increasing stress levels are driving the growth of the male infertility market.
How is the male infertility market segmented by product, application, and end-user?
The male infertility market covered in this report is segmented –
1) By Treatment Type: Medication, Surgery, Assisted Reproductive Technology
2) By Test Type: Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types
3) By Distribution Channel: Hospitals Pharmacies, Pharmacies And Drug Stores, Online Pharmacies
4) By End-User: Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users
Subsegments:
1) By Medication: Hormone Treatments, Gonadotropins, Antibiotics, Antiestrogens, Dopamine Agonists
2) By Surgery: Varicocelectomy, Vasovasostomy, Epididymovasostomy, Transurethral Resection of the Ejaculatory Duct (TURED), Sperm Retrieval Procedures
3) By Assisted Reproductive Technology (ART): In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Sperm Donation, Cryopreservation Of Sperm
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/male-infertility-global-market-report
What evolving trends are creating new opportunities in the male infertility market?
Major companies operating in the male infertility market are focusing on strategic partnership approaches to improve access to advanced fertility treatments across global markets. Strategic partnerships are collaborations between organizations that combine resources and expertise to achieve shared objectives. They help drive innovation, broaden market presence, and enhance R&D efforts. For instance, in June 2024, Ferring Pharmaceuticals, a Switzerland-based pharmaceutical company, partnered with Posterity Health, a US-based male fertility clinic, to introduce a male fertility program on Ferring’s Fertility Out Loud platform to educate men about their fertility. This initiative offers men a confidential online assessment and educational resources developed by reproductive urologists to help them understand their fertility status and reduce the stigma around male infertility, which contributes to up to 50% of infertility cases. The program aims to empower men to take early action, potentially improving the couple’s path to parenthood by addressing male fertility issues sooner and more conveniently through digital tools and telehealth.
Which leading companies are dominating the male infertility market landscape?
Major companies operating in the male infertility market are Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., NYU Langone Hospitals, Sun Pharmaceutical Industries Ltd., Cipla Limited, Ferring Pharmaceuticals, Fortis Healthcare, Vitrolife, Max Healthcare, CinnaGen Co., Aytu BioScience Inc., Zydus Hospitals and Healthcare Research Private Limited, Apricus Biosciences Inc., SCSA Diagnostics Inc., Andrology Solutions, Halotech DNA, Indira IVF, Conduit Pharmaceuticals, Shree IVF Clinics
Which geographic areas are expected to offer the highest growth opportunities in themale infertility market?
North America was the largest region in the male infertility market in 2024. The regions covered in the male infertility market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Male Infertility Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24286&type=smp
Need Customized Data On Male Infertility Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24286&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
